Toronto Institute Collaborates with AB Sciex on New Mass Spec Platform

Mount Sinai's Samuel Lunenfeld Research Institute will use AB Sciex's new mass spectrometry platform, which is still in development, in its proteomics-focused disease studies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.